These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7532799)

  • 21. In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors.
    Gotsis ED; Fountas K; Kapsalaki E; Toulas P; Peristeris G; Papadakis N
    Anticancer Res; 1996; 16(3B):1565-7. PubMed ID: 8694527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.
    Arrieta O; Garcia E; Guevara P; Garcia-Navarrete R; Ondarza R; Rembao D; Sotelo J
    Cancer; 2002 Jun; 94(12):3210-8. PubMed ID: 12115353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma.
    Nagashima H; Sasayama T; Tanaka K; Kyotani K; Sato N; Maeyama M; Kohta M; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
    J Neurooncol; 2018 Jan; 136(2):317-326. PubMed ID: 29143277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonhistological diagnosis of human cerebral tumors by 1H magnetic resonance spectroscopy and amino acid analysis.
    Roda JM; Pascual JM; Carceller F; González-Llanos F; Pérez-Higueras A; Solivera J; Barrios L; Cerdán S
    Clin Cancer Res; 2000 Oct; 6(10):3983-93. PubMed ID: 11051247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors.
    Chen CY; Lirng JF; Chan WP; Fang CL
    J Formos Med Assoc; 2004 Jun; 103(6):448-58. PubMed ID: 15278190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P-31 MR spectroscopy of normal human brain and brain tumors.
    Hubesch B; Sappey-Marinier D; Roth K; Meyerhoff DJ; Matson GB; Weiner MW
    Radiology; 1990 Feb; 174(2):401-9. PubMed ID: 2296651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton-decoupled 31P MRS in untreated pediatric brain tumors.
    Albers MJ; Krieger MD; Gonzalez-Gomez I; Gilles FH; McComb JG; Nelson MD; Blüml S
    Magn Reson Med; 2005 Jan; 53(1):22-9. PubMed ID: 15690498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of ornithine decarboxylase (ODC) and polyamine levels as biochemical markers of malignancy in human brain tumors.
    Ernestus RI; Röhn G; Schröder R; Klug N; Hossmann KA; Paschen W
    Acta Histochem Suppl; 1992; 42():159-64. PubMed ID: 1584960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain tumors: a multimodality approach with diffusion-weighted imaging, diffusion tensor imaging, magnetic resonance spectroscopy, dynamic susceptibility contrast and dynamic contrast-enhanced magnetic resonance imaging.
    Brandão LA; Shiroishi MS; Law M
    Magn Reson Imaging Clin N Am; 2013 May; 21(2):199-239. PubMed ID: 23642551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours.
    Fayed N; Modrego PJ
    J Neurooncol; 2005 May; 72(3):261-5. PubMed ID: 15937650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A reliable protocol for colorimetric determination of iron oxide nanoparticle uptake by cells.
    Deda DK; Cardoso RM; Uchiyama MK; Pavani C; Toma SH; Baptista MS; Araki K
    Anal Bioanal Chem; 2017 Nov; 409(28):6663-6675. PubMed ID: 28918472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinoembryonic antigen in patients with intracranial tumors.
    Suzuki Y; Tanaka R
    J Neurosurg; 1980 Sep; 53(3):355-60. PubMed ID: 7420150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings.
    Chiang IC; Kuo YT; Lu CY; Yeung KW; Lin WC; Sheu FO; Liu GC
    Neuroradiology; 2004 Aug; 46(8):619-27. PubMed ID: 15243726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy.
    Meyerand ME; Pipas JM; Mamourian A; Tosteson TD; Dunn JF
    AJNR Am J Neuroradiol; 1999 Jan; 20(1):117-23. PubMed ID: 9974066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
    Caivano R; Lotumolo A; Rabasco P; Zandolino A; D'Antuono F; Villonio A; Lancellotti MI; Macarini L; Cammarota A
    Int J Neurosci; 2013 Aug; 123(8):537-43. PubMed ID: 23390934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urocortin expression in human pituitary gland and pituitary adenoma.
    Iino K; Sasano H; Oki Y; Andoh N; Shin RW; Kitamoto T; Totsune K; Takahashi K; Suzuki H; Nagura H; Yoshimi T
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3842-50. PubMed ID: 9360550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of brain tumors by MRS, DWI and Ki-67 labeling index.
    Calvar JA; Meli FJ; Romero C; Calcagno ML; Yánez P; Martinez AR; Lambre H; Taratuto AL; Sevlever G
    J Neurooncol; 2005 May; 72(3):273-80. PubMed ID: 15937653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance spectroscopy of the musculoskeletal system.
    Burt CT; Koutcher J; Roberts JT; London RE; Chance B
    Radiol Clin North Am; 1986 Jun; 24(2):321-31. PubMed ID: 3459210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of quantitative peritumoural perfusion and proton spectroscopic magnetic resonance imaging evaluation in differentiating brain gliomas from solitary brain metastases.
    Sparacia G; Gadde JA; Iaia A; Sparacia B; Midiri M
    Neuroradiol J; 2016 Jun; 29(3):160-7. PubMed ID: 26988081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.